LI
ACAD icon

LMCG Investments’s Acadia Pharmaceuticals ACAD Stock Holding History

LMCG Investments’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$4.21M Buy
+127,371
New +$5.3M 0.09% 313
2015
Q1 		– Sell
-103,666
Closed -$3.29M – 536
2014
Q4 		$3.29M Buy
103,666
+8,376
+9% +$238K 0.07% 307
2014
Q3 		$2.36M Buy
95,290
+39,413
+71% +$922K 0.05% 328
2014
Q2 		$1.26M Buy
55,877
+21,507
+63% +$449K 0.03% 374
2014
Q1 		$836K Buy
34,370
+728
+2% +$18.4K 0.02% 393
2013
Q4 		$841K Buy
+33,642
New +$794K 0.02% 389

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LMCG Investments's ACAD Position: Q3 2015 in Review

LMCG Investments opened a new position in Acadia Pharmaceuticals (ACAD) in Q3 2015: 127,371 shares worth $4.21M. The stake represents 0.09% of the portfolio and ranks #313 among its holdings. This is a return to the name: LMCG Investments previously reported a position in ACAD as recently as Q4 2014.

LMCG Investments first reported a position in ACAD in Q4 2013 and has held it in 6 quarters since. 188 funds tracked by Wall St. Rank hold ACAD as of Q3 2015.

  • LMCG Investments held 127,371 shares of Acadia Pharmaceuticals worth $4.21M as of Q3 2015.
  • Acadia Pharmaceuticals was a new LMCG Investments position in Q3 2015.
  • Acadia Pharmaceuticals made up 0.09% of LMCG Investments's portfolio in Q3 2015, its #313 holding.
  • LMCG Investments first reported a position in Acadia Pharmaceuticals in Q4 2013 and has held it in 6 quarters since.
  • 188 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2015.

Based on LMCG Investments's 13F filing for Q3 2015, filed 4 Nov 2015.